| Conferences > Microfluidics, Circulating Biomarkers & Exosomes Asia 2020 > Keynote Speakers |
| Register | Login |
Moran BercoviciAssociate Professor, Faculty of Mechanical Engineering; Head, Technion Microfluidic Technologies Laboratory, Technion, Israel Institute of Technology Moran Bercovici is an Associate Professor of Mechanical Engineering and Biomedical Engineering at Technion – Israel Institute of Technology. His lab combines experimental, analytical, and computational tools to study problems characterized by coupling between fluid mechanics, heat transfer, electric fields, chemical reactions, and biological processes. He is equally interested in understanding basic physical mechanisms and in leveraging them to create new tools and technologies across different disciplines. His current focus areas are in rapid prototyping, adaptive optics, microscale flow control, configurable microstructures, and lab-on-chip systems. Moran holds a PhD in Aeronautics and Astronautics from Stanford University, worked as postdoctoral fellow at Stanford School of Medicine, and was a Harrington Faculty Fellow at the University of Texas at Austin. He authored and co-authored over 50 articles in top peer-reviewed journals, is the inventor of more than 20 patents, and is the recipient of several awards including the EU ERC Starting Grant, and the Blavatnik Prize – considered one of the most prestigious awards to young scientists in Israel. |
Yoon-Kyoung ChoProfessor, Biomedical Engineering, Ulsan National Institute of Science & Technology; Group leader, IBS; FRSC, Fellow of Royal Society of Chemistry Yoon-Kyoung Cho is a full professor of Biomedical Engineering at UNIST and a group leader in the Center for Soft and Living Matter at the Institute for Basic Science (IBS), Republic of Korea. She is a member of the National Academy of Engineering of Korea (NAEK) and a Fellow of Royal Society of Chemistry (FRSC). She serves as a director at the Chemical and Biological Microsystems Society (CBMS) and an associate editor for Lab on a chip. She received her Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign (UIUC) in 1999, having obtained her M.S. and B.S. in Chemical Engineering from POSTECH in 1994 and 1992, respectively. She worked as a senior researcher (1999–2008) at Samsung Advanced Institute of Technology (SAIT), where she helped create biomedical in vitro diagnostic instruments. Her research spans a broad spectrum from fundamental scientific exploration to translational efforts, focusing primarily on microfluidics and nanomedicine. Her current research topics include a lab-on-a-disc for the detection of rare cells and biomarkers, quantitative analysis of single cells, and system analysis of cellular communication. She published over 135 journal papers and over 205 issued patents, many of which helped Samsung Electronics and two start-ups (Clinomics and LabSpinner) build commercial products. Discover more at http://fruits.unist.ac.kr. |
Yong Song GhoProfessor, Pohang University of Science And Technology (POSTECH) Dr. Yong Song Gho is a biochemist and full professor at Pohang University of Science and Technology (POSTECH) in Pohang, Republic of Korea. Since 2000, his study is focused on the extracellular vesicles (also called exosomes and microvesicles) derived from mammalian cells and bacteria. His more recent goals are translational researches on exosome-mimetics for the development of vaccines and drug delivery system against cancer and bacterial infection. His group recently opened a free web-based database, ‘EVpedia (http://evpedia.info)’ to trigger the advancement in systemic and comprehensive studies of the extracellular vesicles. |
Hyo-Il JungProfessor, Yonsei University Hyo-Il Jung is a Professor in the School of Mechanical Engineering, Yonsei University, Republic of Korea. He received his Ph.D. (Physical Biochemistry) degree from University of Cambridge, United Kingdom. His research includes the development of biosensors and analytical system for human healthcare and has contributed to the founding of a start-up company. He also serves as a technical advisor to several in vitro diagnostics companies. He is author of over 100 journals articles and owns over 40 patents. |
In-San KimPrincipal Investigator and Professor, Korea Institute Science and Technology/Korea University In-San Kim is principal research scientist of Biomedical Research Institute at Korea Institute of Science and Technology since 2014 and also professor of KU-KIST Graduate School of Converging Science and Technology, Korea University since 2015. He received his M.D. and Ph.D. degrees from Kyungpook National University (KNU) Medical School. After a postdoctoral training in Dr. Benoit deCrombrugghe’s laboratory of Department of Molecular Genetics of M. D. Anderson Cancer Center, he became a professor of the KNU medical school and promoted to a Full Professor. He found Korean Society of Matrix Biology and served as the first president. He also served as president of Korean Society of Molecular Imaging from 2013 to 2015 and Korean Society of Cell Biology from 2007 to 2009. Currently he is serving as vice-president of Korean Society of Biochemistry and Molecular Biology since 2015. He is a fellow of the Korean Academy of Science & Technology and a member of the National Academy of Medical Science of Korea. He is serving in a few government committees including Health Technology Policy Committee, Ministry of Health & Welfare, Advisory board, Korea National Institute of Health, and Bio-Health division, National Science & Technology Commission. He has been working on cell adhesion molecules and extracellular matrix proteins and their roles in tumor and other chronic diseases. He has expanded his interests in the development of drugs based on nanocage proteins and exosomes particularly harnessing immune system for cancer control. He has published more than 260 peer-reviewed papers and filed several patents. |
Sai Kiang LimResearch Director, Institute of Medical Biology, A*STAR Dr Sai-Kiang Lim graduated with B.Sc (Hons), NUS. PhD SUNY at Buffalo and did post-doctoral training Columbia University. She led independent research groups at NUMI, NUS (1996-2001), Genome Institute of Singapore (2002-2007) and then Institute of Medical Biology (2007-present). The current research interest in her lab is the study of extracellular vesicles (EVs) for the development of therapeutics and diagnostics as well as artificial lipid membrane vesicles. |
Jan LötvallProfessor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles Jan Lötvall is Professor at the Institute of Medicine at Göteborg University since 2002 where he directs a research laboratory studying extracellular vesicles. He is a medical specialist in both Clinical Allergy and Clinical Pharmacology, and has a long-term experience in translational studies in primarily inflammation, but also cancer. He was first elected President of the International Society for Extracellular Vesicles (ISEV, 2011-2016), a rapidly growing non-profit organisation in the field of exosomes, microvesicles and other extracellular vesicles (www.isev.org; >1100 members). The research line focusing on extracellular vesicle biology has received extensive international recognition, as the lab was first to discover the ability of exosomes to shuttle RNA between cells in 2007. During the period of May 2016 to January 2018, JL served as Chief Scientist at Codiak BioSciences, a startup biotech company focusing on developing exosomes as a therapeutic platform. From January 2018, JL was the founding editor of the journals “Clinical and Translational Allergy” (2011, IF 3.239) and Journal of Extracellular Vesicles (JEV: IF 14.9). JL is the current Editor-in-Chief of JEV since August 2019. He is also the Chief Executive Officer and Chief Scientific Officer of Exocure Biosciences, a privately held vesicle therapeutics company. |
Dominique PV de KleijnProfessor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands Prof. Dr. Dominique PV de Kleijn is molecular biologist and chemist and professor of Exp. Vascular Surgery at UMC Utrecht and professor at the Netherlands Heart Institute. From 2012 to 2016, he was Research Professor of Surgery at NUS/NUHS and preclinical director of the Cardiovascular Research Institute (CVRI) Singapore. He was until 2016 professor of Cardiovascular Immunology and co-chair of Experimental Cardiology at UMC Utrecht. Since 1997 he is coordinating cardiovascular research from basic science, animal myocardial infarction and atherosclerotic studies (pig and sheep) towards clinical biobanking studies. His research interests are: The innate immune system in cardiovascular disease and atherosclerosis & Biomarkers predictive for primary & secondary events with a focus on plasma extracellular vesicles. He has more then 275 publications and a H-factor of 78. |
Steve SoperFoundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas Prof. Soper is currently a Foundation Distinguished Professor in Chemistry and Mechanical Engineering at the University of Kansas, Lawrence. Prof. Soper also holds an appointment at Ulsan National Institute of Science and Technology in Ulsan, South Korea, where he is a World Class University Professor. He is also serving as a Science Advisor for a number of major worldwide companies. Prof. Soper is currently on the Editorial Board for Scientific Reports and Journal of Micro- and Nanosystems. |
Hidetoshi TaharaDeputy Executive Director, Industry-Academia Collaboration; Professor, Department of Cellular and Molecular Biology; Head, The Research Center for Drug development and Biomarker Discovery, Hiroshima University Professor Tahara is Professor at Hiroshima University and a key opinion leader in the field of extracellular vesicles (EVs). |
